Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,542,749
-$167,128 QoQ
Shares Held
34,637
-4.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#480
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. AMGN ranks #3 (13.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
This page
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,542,749 | 34,637 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $12,709,877 | 36,123 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $11,846,330 | 36,193 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $9,967,021 | 35,319 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $9,920,051 | 35,529 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,434,507 | 36,702 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,612,663 | 36,881 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $11,500,318 | 35,692 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $11,281,944 | 36,108 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $10,407,248 | 36,604 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $10,806,221 | 37,519 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $10,246,742 | 38,126 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,581,294 | 38,651 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,681,361 | 40,047 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $10,757,209 | 40,958 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,452,824 | 41,938 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,263,853 | 42,186 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,401,161 | 43,012 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,333,096 | 45,931 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $10,305,656 | 48,463 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $29,450,606 | 120,823 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $31,656,095 | 127,230 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $29,565,642 | 128,591 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $33,558,269 | 132,036 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $30,756,143 | 130,400 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $25,796,580 | 127,246 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||